What Is Sanofi (SNY) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Sanofi's intrinsic value is estimated at $51.65, presenting a divided outlook at the current price of $44.00. With an average implied return of +17.4% across a split 7–4 (bull–bear) consensus, the model spread of +156.4% underscores analytical uncertainty. Notably, RCMH-DCF sees the most upside at +116.1% (fair value: $95.10), while Dynamic NAV is the most conservative at -40.3% ($26.26). The spread between these extremes — +156.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About SNY?
13 of 13 models are currently active for SNY. Of these, 7 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates SNY's intrinsic value at $90.89, implying +106.6% upside from the current price. See which stocks rank higher →
How Does SNY Rank in Pharmaceutical Preparations?
Among 440 Pharmaceutical Preparations stocks, SNY ranks #13 by Quality of Company score. CirclFi's QOC score of 9.4/10 evaluates 32 fundamental signals. A score of 9.4 places SNY in the top tier.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Sanofi's positioning within the Pharmaceutical Preparations segment means that R&D productivity ratio plays an outsized role in fundamental analysis. The sector's unique characteristics — including orphan drug designation — shape both the opportunity set and risk profile.
Is SNY a Value Trap?
The Value Trap algorithm is not active for SNY. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Sanofi. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Sanofi scores 9.4 out of 10 on our 32-signal quality assessment, a elite rating that ranks among the highest-quality businesses in our coverage universe. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +156.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every SNY valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across SNY's 13 active models, average confidence is 47%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad